Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR ‐mutated NSCLC treated with afatinib

BACKGROUND: This study aimed to comprehensively evaluate the efficacy and toxicity of afatinib in patients with sarcopenia, an important prognostic factor for treatment efficacy and toxicity in patients with cancer. METHODS: The clinical features of patients with advanced NSCLC treated with frontlin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chen‐Te, Hsu, Ping‐Chih, Chang, John Wen‐Cheng, Chang, Ching‐Fu, Huang, Chen‐Yang, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Fang, Yueh‐Fu, Wu, Chiao‐En
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481145/
https://www.ncbi.nlm.nih.gov/pubmed/37525557
http://dx.doi.org/10.1111/1759-7714.15017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481145/
https://www.ncbi.nlm.nih.gov/pubmed/37525557
http://dx.doi.org/10.1111/1759-7714.15017

Ejemplares similares